A notable increase in the expression of IL-6 in Hepatocellular carcinoma (HCC) cells was observed in our previous research, indicating that the administration of BEZ235 could potentially induce an inflammatory response within the body (15). Here, IL6 is linked to hepatocellular carcinoma.